Cancer diagnostics News and Research

RSS

Researchers test new treatment protocol for lymphoma

Lymphoma is a type of blood cancer that develops from lymphocytes (a type of white blood cell). It has many subtypes.

29 May 2020

Stand Up To Cancer hails FDA approval of new treatment option for aggressive prostate cancer

A recent FDA approval supported by Stand Up To Cancer research provides a new treatment option for patients with an aggressive form of prostate cancer.

27 May 2020

Supportive care for reducing fatigue may not be sufficiently adhered to by breast cancer patients

Cancer-related fatigue is a prevalent and potentially persistent issue among breast cancer survivors, which can prevent them from returning to their previous life well after treatment ends and they are declared free of disease.

22 May 2020

Breast cancer survivors underutilize supportive care to relieve cancer-related fatigue

22 May 2020

Next-gen nano technologies set to transform the medical industry

Next-gen nano technologies that can prevent infection and diagnose disease are set to transform the medical industry as this important UniSA research is awarded more than $2 million dollars under the National Health and Medical Research Council 2021 Investigator Grants.

21 May 2020

Just a little physical activity can have big impact for women with high-risk breast cancer

Results of a comprehensive analysis of exercise and its protective role for high-risk breast cancer patients show that women who exercise not only live longer, but also are more likely to remain cancer-free after their treatment. What's more, the study suggests that even a modest amount of exercise can be beneficial.

21 May 2020

Computational immunology paves the way for SARS-CoV-2 peptide cocktail vaccine candidate

By employing an immunoinformatics approach, a new study available on the preprint server bioRxiv* shows how the combination of peptides designed from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid phosphoprotein and spike glycoprotein may trigger an improved immunological response with respectable safety profile, informing, in turn, further vaccine development.

21 May 2020

Study: Personalized ovarian cancer risk prediction reduces worries among a majority of women

Offering personalised ovarian cancer risk prediction to women shows that 98 per cent of participants felt less worried after finding out their ovarian cancer risk status, according to a study led by Queen Mary University of London.

19 May 2020

New eco-evolutionary mathematical model can predict prostate cancer aggressiveness

Prostate cancer is the most common cancer in men. One in nine men will be diagnosed during their lifetime. While most men will not die from prostate cancer, there is a small subset of patients whose disease is so aggressive at the time of diagnosis that surgery and radiation are not able to control their cancer.

14 May 2020

Mammogram screening and high fiber diet help combat breast cancer

The key to spotting breast cancer and reducing the risk of fatal disease is early detection and screening. Diagnosing the illness early on helps improve health outcomes. New research shows that participation in mammography screening substantially reduces the rate of advanced and fatal breast cancer.

12 May 2020

Researchers report decline in cancer diagnoses due to COVID-19 crisis

Cancer care has dramatically changed as a result of the measures taken during the COVID-19 pandemic: many patients have not been going to their GPs, or putting it off, and have been referred to the hospital later.

11 May 2020

COVID-19 pandemic will bring additional cancer deaths

With over 3.25 million people infected, healthcare systems of even the most developed nations are overwhelmed. Cancer patients and survivors, for example, are particularly vulnerable during this epidemic and not only because of their increased vulnerable immunocompromised state, which makes them prone to the infection. They are also at risk of missing out on essential cancer care due to the unavailability of resources.

30 Apr 2020

Horizon Discovery extends coverage of OncoSpan reference standards to FFPE and Liquid Biopsy

Horizon Discovery Group plc, today announced it has added two new sample formats to its cell-based OncoSpan reference standards for cancer diagnostic assays.

From Revvity 29 Apr 2020

Top biochip firms speed up development of fast, reliable COVID-19 test

Surfix B.V., together with its shareholders Qurin Diagnostics B.V. and LioniX International B.V., already successfully developing bio-photonic nanochips for cancer detection and other applications, today announces an accelerated development plan to allow mass-scale COVID-19 diagnosis and immunity detection with the financial support and in close collaboration with PhotonDelta.

24 Apr 2020

Fast and simple testing may determine the uptake of lung cancer screening

Value in Health, the official journal of ISPOR - the professional society for health economics and outcomes research, announced today the publication of new research showing that uptake of lung cancer screening may depend on making testing fast and convenient.

22 Apr 2020

Cancer diagnostics News and Research

Researchers test new treatment protocol for lymphoma

Stand Up To Cancer hails FDA approval of new treatment option for aggressive prostate cancer

Supportive care for reducing fatigue may not be sufficiently adhered to by breast cancer patients

Breast cancer survivors underutilize supportive care to relieve cancer-related fatigue

Next-gen nano technologies set to transform the medical industry

Just a little physical activity can have big impact for women with high-risk breast cancer

Computational immunology paves the way for SARS-CoV-2 peptide cocktail vaccine candidate

Study: Personalized ovarian cancer risk prediction reduces worries among a majority of women

New eco-evolutionary mathematical model can predict prostate cancer aggressiveness

Mammogram screening and high fiber diet help combat breast cancer

Researchers report decline in cancer diagnoses due to COVID-19 crisis

COVID-19 pandemic will bring additional cancer deaths

Horizon Discovery extends coverage of OncoSpan reference standards to FFPE and Liquid Biopsy

Top biochip firms speed up development of fast, reliable COVID-19 test

Fast and simple testing may determine the uptake of lung cancer screening

Study finds NCCN Guidelines for Patients listed among the most trustworthy online resources

Greater occurrence of infections correlates with future cancer diagnosis

Cancer Research UK calls for mass Covid-19 testing to prevent unnecessary cancer deaths

Chronic stress can influence the efficacy of radiation therapy, study suggests

Knowledge of cancer diagnosis contributes to longer survival time

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News